BOM Brabant Ventures

Regenerative Stents

Developer of tumor localization technology designed to improve care for cancer patients. The company's technology uses a tiny implanted magnetic seed to precisely mark the tumor and a detection probe to accurately locate the seed during surgery, enabling patients to receive affordable cancerous tumor surgery and improved surgical care.

We started ChainCargo because of a strong inner urge to approach logistics differently. We believe that with the current capacity we can transport more. Simply by smarter use of the available capacity in existing transport movements. We want to change the way of thinking in logistics and we believe that we can transport more volume and more efficient with the current capacity of vehicles. We do that by making available capacity visible and accessible. This is realized via our platform which connects the shipment to the carrier based on sustainable business rules. An optimization for: Carriers: a better occupancy of their loading capacity Shippers: online order booking platform, live track & trace and more cost efficient Society: less pressure on infrastructure and reduction of CO2 emissions

Developer of business management platform intended to create and manage plug-and-play edge artificial intelligence (AI) services. The company's platform offers efficient AI or ML model deployment, monitoring, and governance in the cloud, in a browser, on the edge, and any device with a minimal amount of memory, enabling clients to access AI services with secure, modular, and run fully locally.

Microsure B.V., founded in 2016 and based in Son, Netherlands, specializes in the development of advanced robotic systems for microsurgery. The company's flagship product, MUSA, is designed to assist surgeons in performing intricate procedures, including lymphatic surgery, free flap surgery, and hand surgery. The Microsure motion stabilizer system enhances surgical precision and control, addressing the physical limitations faced by microsurgeons. This technology aims to improve the quality of microsurgical procedures, thus expanding treatment options for patients. The system has demonstrated its efficacy in clinical trials, successfully facilitating microsurgical operations for lymphedema at Maastricht UMC+. Microsure is focused on accelerating the market introduction and sales of its innovative surgical systems.

Shypple B.V. is a logistics company based in Rotterdam, Netherlands, founded in 2016. It provides a comprehensive range of services including door pick-ups, customs brokerage, ocean, air, and rail freight, as well as on-demand warehousing. The company also offers trucking, finance, insurance, and customs services, supported by a digital freight forwarding platform. This central web application enhances visibility across the supply chain, enabling efficient collaboration among all parties involved in international trade. Shypple's platform allows users to compare pricing from various carriers and optimize routing options, facilitating quicker and more transparent management of freight shipments. The company prides itself on offering 24/7 support, ensuring that clients receive attentive service without compromising the personal touch typical of traditional freight forwarders.

Xyall is a global innovator in molecular pathology.

Knowingo+ is a discover the smartest mobile learning platform.

Citryll is a private pharmaceutical company that develops pharmaceutical drugs used to treat autoimmune and other human diseases. The company offers formation, function, and clearance of NETs downstream of the protein citrullination pathway catalyzed by Peptidylarginine Deiminase (PAD) enzymes that enable doctors to help in the treatment of lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis and organ damage due to sepsis. Citryll was established in 2015 and is headquartered in Oss, The Netherlands.

Dens B.V., founded in 2018 and based in Helmond, the Netherlands, specializes in renewable energy solutions by manufacturing generators that convert formic acid into hydrogen and subsequently into electricity. The company's flagship product, DENS X2, serves as a sustainable and silent alternative to traditional diesel generators, particularly in areas lacking power supplies. Dens B.V. focuses on developing machines that store and regenerate renewable energy, ensuring a reliable energy source regardless of time and location. This innovation aims to provide clients with a zero-emission power solution that minimizes environmental impact while eliminating the noise associated with conventional generators.

Cytosmartb develops smart devices to use in laboratories around the world. It provides CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni for businesses and individuals. The clients of the company are Fontys, THM, Roche, University of Oxford, EMBL, and University of St Andrews. Cytosmart is a Netherlands-based company that was founded in 2012.

ENPICOM is an innovative bioinformatics software engineering company dedicated to supporting scientists in biopharma and academic research centers with groundbreaking products and customized solutions to improve and accelerate the discovery and development of novel immunotherapies and vaccines. Leveraging a unique mix of biological knowledge, bioinformatics method development, and software engineering skills, ENPICOM developed the ImmunoGenomiX (IGX) Platform, an innovative platform to manage, store, analyze, visualize, and compare immune repertoire sequencing data from T and B cell receptors

Additive Industries B.V., established in 2012 and based in Eindhoven, Netherlands, specializes in the design and manufacture of industrial metal additive manufacturing systems. The company focuses on transitioning metal additive manufacturing from laboratory settings to practical applications in various high-end industrial markets, including aerospace, automotive, medical technology, and high-tech equipment. By offering a modular 3D printing system along with a seamlessly integrated information platform, Additive Industries enhances reproducibility, productivity, and flexibility in manufacturing processes. The company boasts a team of highly experienced engineers and professionals drawn from the high-tech equipment ecosystem in Eindhoven, contributing to its innovative approach in redefining additive manufacturing applications.

Biopharmaceutical company developing novel therapeutic solutions to treat neurodegenerative diseases

Cytosmartb develops smart devices to use in laboratories around the world. It provides CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni for businesses and individuals. The clients of the company are Fontys, THM, Roche, University of Oxford, EMBL, and University of St Andrews. Cytosmart is a Netherlands-based company that was founded in 2012.